Literature DB >> 24982452

Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity?

Preetesh Jain1, Chi Young Ok1, Sergej Konoplev1, Keyur P Patel1, Jeffrey Jorgensen1, Zeev Estrov1, Raja Luthra1, Hagop Kantarjian1, Farhad Ravandi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24982452     DOI： 10.1200/JCO.2013.50.9661

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Removing a hair of doubt about BRAF targeting.

Authors:  Robert J Kreitman
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

2.  Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Oncologist       Date:  2019-10-18

Review 3.  Update on hairy cell leukemia.

Authors:  Robert J Kreitman; Evgeny Arons
Journal:  Clin Adv Hematol Oncol       Date:  2018-03

Review 4.  Development of Recombinant Immunotoxins for Hairy Cell Leukemia.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2020-08-03

5.  Expression of the muscle-associated gene MYF6 in hairy cell leukemia.

Authors:  Evgeny Arons; Hong Zhou; Mark Sokolsky; Daniel Gorelik; Katherine Potocka; Sarah Davies; Erin Fykes; Katherine Still; Daniel C Edelman; Yonghong Wang; Paul S Meltzer; Mark Raffeld; Adrian Wiestner; Liqiang Xi; Hao-Wei Wang; Maryalice Stetler-Stevenson; Constance Yuan; Robert J Kreitman
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.